Is the Association Between Psoriatic Arthritis and Obesity Bidirectional? Managing Obesity to Reduce Comorbid Risk
Released On
March 7, 2025
Expires On
March 7, 2026
Media Type
Internet
Completion Time
70 minutes
Specialty
Rheumatology
Topics
Arthritis, Obesity, Psoriasis
This activity is provided by Med Learning Group.
This activity is supported by an educational grant from Lilly.
Credit Available
- Physicians — 1.0 AMA PRA Category 1 Credit™
- Nurses — 1.0 ANCC contact hour
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
This CME initiative is designed to meet the educational needs of community-based rheumatologists, nurse practitioners, and physician’s assistants who treat patients with PsA.
Program Overview
This program offers healthcare providers who care for patients with psoriatic arthritis an interactive, case-based learning experience on how obesity affects inflammatory activity, thus increasing the risk of PsA and its associated comorbidities. This program will also outline the safety and efficacy data on the treatment of obesity in patients with psoriatic arthritis, as well as strategies to most effectively utilize multidisciplinary teams in the care of obese patients with PsA.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Assess how obesity contributes to the underlying inflammatory activity that increases the risk of PsA and its associated comorbidities
- Utilize efficacy and safety data in the treatment of obesity in patients with PsA
- Apply strategies to involve the multidisciplinary team in the care of obese patients with PsA
Faculty
Ethan T. Craig, MD, MHS
Assistant Professor of Clinical Medicine
Vice Chief for Clinical Affairs
University of Pennsylvania
Philadelphia, PA
Accreditation Statement
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation Statement
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Nursing (ANCC) Credit Designation
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
Disclosures of Conflicts of Interest
Ethan T. Craig, MD
Consultant: Amgen, Novartis, Janssen, Calico Biosciences
Instructions for Participation and Credit
Method of Participation
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CE questions, please contact Med Learning Group at: [email protected].
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
